4.1 Article

Different effects of magnetic field on drug activity in human uterine sarcoma cell lines MES-SA and MES-SA/Dx5

期刊

ELECTROMAGNETIC BIOLOGY AND MEDICINE
卷 41, 期 3, 页码 343-351

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/15368378.2022.2095645

关键词

Magnetic field (MF); MDR1; drug transporter; doxorubicin; daunorubicin; etoposide; cisplatin

资金

  1. KAKENHI JSPS [19K12819]

向作者/读者索取更多资源

It has been found that a 60 Hz magnetic field can enhance the activity of certain drugs (such as cisplatin, doxorubicin, and daunorubicin) in human uterine sarcoma cells, particularly in cells that overexpress a membrane protein called MDR1. However, the activity of etoposide, another drug, was not affected by the magnetic field. This suggests that the magnetic field may enhance drug uptake into cells by influencing drug influx transporters.
Previous studies reported that combined effect of magnetic field (MF) on cytotoxic drugs in human cancer cells. We focused on the effects of 60 Hz MF on drug activity in human uterine sarcoma MES-SA and drug-resistant variant MES-SA/Dx5 cells that overexpressed the membrane protein MDR1(P-glycoprotein), a drug efflux transporter for doxorubicin, daunorubicin, and etoposide, but not cisplatin. The cisplatin with MF caused 60% decrease in cell viability when compared with no MF treatment, cisplatin alone in MES-SA cells. Even in MES-SA/Dx5 cells, MF exposure equally enhanced cisplatin activity. Then, MF enhanced doxorubicin and daunorubicin activity in MES-SA cells and caused 60% decrease in the cell viability compared with these drugs only but had less effect on these drugs in MES-SA/Dx5 cells. Etoposide activity was unaffected by MF exposure in both cell lines, although etoposide is a MDR1 substrate as with doxorubicin and daunorubicin. Thus, MF had no direct impact on MDR1 in the cell membrane. However, the differences in doxorubicin and daunorubicin activity between MES-SA and MES-SA/Dx5 data revealed that the presence of MDR1 in abundance prevented the enhancing effects of MF on doxorubicin and daunorubicin activity. These results suggested that MF may act in the opposite direction of MDR1, affect the drug influx transporters for doxorubicin and daunorubicin, and facilitate anticancer drug uptake into the cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据